Please login to the form below

Not currently logged in


This page shows the latest Renflexis news and features for those working in and with pharma, biotech and healthcare.

Merck spin-off Organon sees share price jump at Q2 results

Merck spin-off Organon sees share price jump at Q2 results

Its biosimilars business is also growing, with revenues rising by 43% in the second quarter of 2021, driven by US demand for monoclonal antibodies Renflexis (infliximab-abda), for autoimmune diseases, and

Latest news

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Five big changes in the healthcare comms landscape
The world of healthcare has changed very greatly in the five years since The Difference Collective launched. Our agile model and talented team have enabled us to keep pace with...
Early communications in Pharma: How effective pre-approval comms delivers launch success
What communications are required for a successful launch...
Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....